cabergoline has been researched along with Hypertriglyceridemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Okazaki, K; Sugimoto, T; Takeno, A; Yamaguchi, T; Yamamoto, M | 1 |
Bonaventura, MM; Calandra, RS; Huhtaniemi, IT; Lux-Lantos, VA; Poutanen, M; Ratner, LD; Rulli, SB; Stevens, G | 1 |
2 other study(ies) available for cabergoline and Hypertriglyceridemia
Article | Year |
---|---|
Successful Improvement of Metabolic Disorders, Including Osteopenia, by a Dopamine Agonist in a Male Patient with Macro-Prolactinoma.
Topics: Adult; Bone Diseases, Metabolic; Cabergoline; Dopamine Agonists; Ergolines; Glucose Intolerance; Humans; Hypertriglyceridemia; Male; Overweight; Pituitary Neoplasms; Prolactinoma | 2016 |
Hyperprolactinemia induced by hCG leads to metabolic disturbances in female mice.
Topics: Animals; Blood Glucose; Cabergoline; Chorionic Gonadotropin, beta Subunit, Human; Ergolines; Female; Glucose Intolerance; Hyperinsulinism; Hyperprolactinemia; Hypertriglyceridemia; Insulin; Insulin Resistance; Mice; Mice, Transgenic; Prolactin; Triglycerides | 2016 |